Invasion front-specific expression and prognostic significance of microrna in colorectal liver metastases

Cancer Science

Volumn 102, Issue 10, 2011, Pages 1799-1807

  Kahlert, Christoph ^a   Klupp, Fee ^a   Brand, Karsten ^a   Lasitschka, Felix ^a   Diederichs, Sven ^a,b   Kirchberg, Johanna ^a   Rahbari, Nuh ^a   Dutta, Shamik ^a   Bork, Ulrich ^a   Fritzmann, Johannes ^a   Reissfelder, Christoph ^a   Koch, Moritz ^a   Weitz, Juergen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7A; LET 7B; LET 7C; MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 1201; MICRORNA 125B; MICRORNA 1275; MICRORNA 1280; MICRORNA 143; MICRORNA 145; MICRORNA 16; MICRORNA 1826; MICRORNA 1908; MICRORNA 194; MICRORNA 199A; MICRORNA 19B; MICRORNA 22; MICRORNA 23B; MICRORNA 24; MICRORNA 26A; MICRORNA 27B; MICRORNA 30B; MICRORNA 30D; MICRORNA 720; MICRORNA 768; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LIVER METASTASIS; LIVER PARENCHYMA; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; COLORECTAL TUMOR; DISEASE COURSE; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; TUMOR CELL CULTURE;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR CELLS, CULTURED;

EID: 84856241159     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02023.x     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Holzel D, Eckel R, Engel J. Colorectal cancer metastasis frequency, prognosis, and consequences. Chirurg 2009; 80: 331-40.
3. Huang Q, Gumireddy K, Schrier M et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-10.
4. Ma L, Weinberg RA. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 2008; 24: 448-56.
5. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8.
6. Sachdeva M, Mo YY. MicroRNA-145 Suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010; 70: 378-87.
7. Wellner U, Schubert J, Burk UC et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-95.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
9. Zhang W, Dahlberg JE, Tam W. MicroRNAs in tumorigenesis: a primer. Am J Pathol 2007; 171: 728-38.
10. Schepeler T, Reinert JT, Ostenfeld MS et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-24.
11. Schetter AJ, Leung SY, Sohn JJ et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36.
12. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J, Brand K. Invasion frontspecific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 2008; 28: 1459-65.
13. Spaderna S, Schmalhofer O, Hlubek F et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006; 131: 830-40.
14. Illemann M, Bird N, Majeed A et al. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 2006; 4: 293-302.
15. Diaz R, Silva J, Garcia JM et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosom Cancer 2008; 47: 794-802.
16. Brabletz T, Jung A, Reu S et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98: 10356-61.
17. Tsujiura M, Ichikawa D, Komatsu S et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-9.
18. Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67: 5699-707.
19. Gebeshuber CA, Zatloukal K, Martinez J. MiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 2009; 10: 400-5.
20. Muniyappa MK, Dowling P, Henry M et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 2009; 45: 3104-18.
21. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
22. Braun CJ, Zhang X, Savelyeva I et al. P53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008; 68: 10094-104.
23. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 2010; 97: 853-61.
24. Hayashita Y, Osada H, Tatematsu Y et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-32.
25. Sachdeva M, Zhu S, Wu F et al. P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009; 106: 3207-12.
26. Long XB, Sun GB, Hu S et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009; 22: 1189-95.
27. He X, Duan C, Chen J et al. Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett 2009; 583: 3501-7.
28. Cimmino A, Calin GA, Fabbri M et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-9.
29. Ting Y, Medina DJ, Strair RK, Schaar DG. Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochem Biophys Res Commun 2010; 394: 606-11.
30. Mishra PJ, Song B, Wang Y et al. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS ONE 2009; 4: e8445.
31. Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. MiR-24 upregulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010; 46: 204-8.
32. Salvi A, Sabelli C, Moncini S et al. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 2009; 276: 2966-82.
33. Myatt SS, Wang J, Monteiro LJ et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 2010; 70: 367-77.
34. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, Johnson MD. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci USA 2010; 107:2183-8.
35. Lu Y, Ryan SL, Elliott DJ et al. Amplification and overexpression of HsamiR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medul loblastoma. PLoS ONE 2009; 4: e6159.
36. Guo Y, Chen Z, Zhang L et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
37. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS ONE 2009; 4: e6677.
38. Xia HF, He TZ, Liu CM et al. MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem 2009; 23: 347-58.
39. Kim S, Lee UJ, Kim MN et al. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 2008; 283: 18158-66.
40. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 2009; 276: 6689-700.
41. Ng EK, Tsang WP, Ng SS et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009; 101: 699-706.
42. Jakymiw A, Patel RS, Deming N et al. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosom Cancer 2010; 49: 549-59.
43. Shimizu S, Takehara T, Hikita H et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704.
44. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol 2008; 18: 505-16.
45. Wang CJ, Zhou ZG, Wang L et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009; 26: 27-34.
46. Chen X, Guo X, Zhang H et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385-92.
47. Akao Y, Nakagawa Y, Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006; 29: 903-6.
48. Moncini S, Salvi A, Zuccotti P et al. The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration. PLoS ONE 2011; 6: e20038.
49. Lu J, He ML, Wang L et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011; 71: 225-33.
50. Dews M, Homayouni A, Yu D et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38: 1060-5.
51. Maeda K, Nishiguchi Y, Kang SM et al. Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol Rep 2001; 8: 763-6.
52. Mees ST, Mardin WA, Wendel C et al. EP300-a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 2010; 126:114-24.
53. Venugopal SK, Jiang J, Kim TH et al. Liver fibrosis causes down-regulation of miRNA-150 and miRNA-194 in hepatic stellate cells and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2010; 298: 6101-6.
54. Bandapalli OR, Geheeb M, Kobelt D et al. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 2006; 118: 74-89.
55. Lunevicius R, Nakanishi H, Ito S et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 2001; 127: 193-9.